French National AIDS Council issues opinion on the potential benefits of the concept of HIV/AIDS Pre-Exposure Prophylaxis (PrEP)

Publié le | Temps de lecture : 1 minute

Contenu d'archive CNS Santé

The CNS wishes to publish this opinion today, at a time when a committee of experts recommended the FDA to approve a supplemental New Drug Application for an antiretroviral treatment to be used for PrEP.

You will find on this website :

-
 the complete Opinion
-
 the Summary of the Opinion in pdf format
-
 the Press release

image 478

Sur le même thème

Partager cet article